Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

End-of-the-year European launches for protease inhibitors

Dec. 31, 1996

European approval recommended for CMV retinitis Rx

Dec. 30, 1996

Medarex claims bispecific reagents for AIDS therapy

Dec. 30, 1996

Agouron files first NDA submission

Dec. 24, 1996

Novel anti-HIV agent from NCI

Dec. 24, 1996

NanoSystems to develop novel formulation of HIV protease inhibitor

Dec. 23, 1996

IND filed for Cytel HIV therapeutic vaccine

Dec. 23, 1996

The role of host factors in HIV pathogenesis

Dec. 19, 1996

HemispheRx and Temple University enter new agreement for Oragen products

Dec. 19, 1996

MRC offers Fv1 gene for licensing

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...